Literature DB >> 15817684

Defective Vav expression and impaired F-actin reorganization in a subset of patients with common variable immunodeficiency characterized by T-cell defects.

Silvia Rossi Paccani1, Marianna Boncristiano, Laura Patrussi, Cristina Ulivieri, Andreas Wack, Silvia Valensin, Tim R Hirst, Amedeo Amedei, Gianfranco Del Prete, John L Telford, Mario M D'Elios, Cosima T Baldari.   

Abstract

Common variable immunodeficiency (CVID) is a primary immune disorder characterized by impaired antibody production, which is in many instances secondary to defective T-cell function (T-CVID). We have previously identified a subset of patients with T-CVID characterized by defective T-cell receptor (TCR)-dependent protein tyrosine phosphorylation. In these patients, ZAP-70 fails to be recruited to the TCR as the result of impaired CD3zeta phosphorylation, which is, however, not dependent on defective Lck expression or activity. Here we show that neither Fyn nor CD45 is affected in these patients. On the other hand, T-CVID T cells show dramatic defects in the Vav/Rac pathway controlling F-actin dynamics. A significant deficiency in Vav protein was indeed observed; in 3 of 4 patients with T-CVID, it was associated with reduced VAV1 mRNA levels. The impairment in Vav expression correlated with defective F-actin reorganization in response to TCR/CD28 co-engagement. Furthermore, TCR/CD28-dependent up-regulation of lipid rafts at the cell surface, which requires F-actin dynamics, was impaired in these patients. The actin cytoskeleton defect could be reversed by reconstitution of Vav1 expression in the patients' T cells. Results demonstrate an essential role of Vav in human T cells and strongly suggest Vav insufficiency in T-CVID.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15817684     DOI: 10.1182/blood-2004-05-2051

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

Review 1.  Quantitative Imaging Approaches to Study the CAR Immunological Synapse.

Authors:  Malini Mukherjee; Emily M Mace; Alexandre F Carisey; Nabil Ahmed; Jordan S Orange
Journal:  Mol Ther       Date:  2017-06-26       Impact factor: 11.454

2.  B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease.

Authors:  Gaël Mouillot; Maryvonnick Carmagnat; Laurence Gérard; Jean-Luc Garnier; Claire Fieschi; Nicolas Vince; Lionel Karlin; Jean-François Viallard; Roland Jaussaud; Julien Boileau; Jean Donadieu; Martine Gardembas; Nicolas Schleinitz; Felipe Suarez; Eric Hachulla; Karen Delavigne; Martine Morisset; Serge Jacquot; Nicolas Just; Lionel Galicier; Dominique Charron; Patrice Debré; Eric Oksenhendler; Claire Rabian
Journal:  J Clin Immunol       Date:  2010-05-01       Impact factor: 8.317

3.  The distinct role of guanine nucleotide exchange factor Vav1 in Bcl-2 transcription and apoptosis inhibition in Jurkat leukemia T cells.

Authors:  Jie Yin; Ya-juan Wan; Shi-yang Li; Ming-juan Du; Cui-zhu Zhang; Xing-long Zhou; You-jia Cao
Journal:  Acta Pharmacol Sin       Date:  2010-12-13       Impact factor: 6.150

4.  T-cell response to viral antigens in adults and children with common variable immunodeficiency and specific antibody deficiency.

Authors:  L M Haveman; J Scherrenburg; L J Maarschalk-Ellerbroek; P D Hoek; R Schuurman; W de Jager; P M Ellerbroek; B J Prakken; D van Baarle; J M van Montfrans
Journal:  Clin Exp Immunol       Date:  2010-04-09       Impact factor: 4.330

5.  Combined Immunodeficiency Caused by a Novel De Novo Gain-of-Function RAC2 Mutation.

Authors:  Liang Zhang; Zhi Chen; Wenyan Li; Qiao Liu; Yanping Wang; Xuemei Chen; Zhirui Tian; Qiuyun Yang; Yunfei An; Zhiyong Zhang; Huawei Mao; Xuemei Tang; Ge Lv; Xiaodong Zhao
Journal:  J Clin Immunol       Date:  2022-05-21       Impact factor: 8.542

Review 6.  T cell antigen receptor activation and actin cytoskeleton remodeling.

Authors:  Sudha Kumari; Silvia Curado; Viveka Mayya; Michael L Dustin
Journal:  Biochim Biophys Acta       Date:  2013-05-14

7.  Vav1 GEF activity is required for T cell mediated allograft rejection.

Authors:  Dirk Haubert; Jianping Li; Alexander Saveliev; Thomas Calzascia; Esther Sutter; Barbara Metzler; Daniel Kaiser; Victor L J Tybulewicz; Gisbert Weckbecker
Journal:  Transpl Immunol       Date:  2012-03-21       Impact factor: 1.708

8.  Pathogenesis of autoimmunity in common variable immunodeficiency.

Authors:  Klaus Warnatz; Reinhard E Voll
Journal:  Front Immunol       Date:  2012-07-18       Impact factor: 7.561

9.  Transgelin-2 in B-Cells Controls T-Cell Activation by Stabilizing T Cell - B Cell Conjugates.

Authors:  Bo-Ra Na; Min-Sung Kwon; Myoung-Won Chae; Hye-Ran Kim; Chang-Hyun Kim; Chang-Duk Jun; Zee-Yong Park
Journal:  PLoS One       Date:  2016-05-27       Impact factor: 3.240

10.  A CVID-associated variant in the ciliogenesis protein CCDC28B disrupts immune synapse assembly.

Authors:  Nagaja Capitani; Anna Onnis; Francesca Finetti; Chiara Cassioli; Alessandro Plebani; Jlenia Brunetti; Arianna Troilo; Sofia D'Elios; Manuela Baronio; Luisa Gazzurelli; Chiara Della Bella; Daniel D Billadeau; Mario Milco D'Elios; Vassilios Lougaris; Cosima T Baldari
Journal:  Cell Death Differ       Date:  2021-07-22       Impact factor: 12.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.